We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ford Motor (NYSE:F) – The global automaker reported adjusted earnings per share of $0.47 in the second quarter, below the $0.67 expected, impacted by ongoing warranty issues. Revenue...
Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN DIEGO, July 24, 2024 Conference call scheduled for 4:30 p.m. ET today VK2735 to...
U.S. index futures fell in pre-market trading on Wednesday, impacted by recent financial results from tech giants Tesla and Alphabet. Investors are watching for potential Federal Reserve interest...
Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024 PR Newswire SAN DIEGO, July 17, 2024 Conference Call Scheduled for Wednesday, July 24 at 4:30 p.m. Eastern...
Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association PR Newswire SAN DIEGO, June...
Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) PR Newswire SAN DIEGO...
Viking Therapeutics to Participate at Upcoming Investor Conferences PR Newswire SAN DIEGO, May 30, 2024 SAN DIEGO, May 30, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions